Vera, A. A., Wilke, C. T., Iv, J. A. A. V., Bulat, M. L., Ohr, J., Zandberg, D. P., … Mowery, Y. M. (2025). High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab plus /-Docetaxel in Previously-Irradiated HNSCC. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 123, pp. S144–S144).

Vera, A. A., C. T. Wilke, JAA Vargo Iv, M. L. Bulat, J. Ohr, D. P. Zandberg, Z. Rahman, et al. “High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab plus /-Docetaxel in Previously-Irradiated HNSCC.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 123:S144–S144, 2025.

Vera AA, Wilke CT, Iv JAAV, Bulat ML, Ohr J, Zandberg DP, et al. High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab plus /-Docetaxel in Previously-Irradiated HNSCC. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2025. p. S144–S144.

Vera, A. A., et al. “High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab plus /-Docetaxel in Previously-Irradiated HNSCC.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 123, no. 1, 2025, pp. S144–S144.

Vera AA, Wilke CT, Iv JAAV, Bulat ML, Ohr J, Zandberg DP, Rahman Z, Kim S, Johnson JT, Petro D, Marks S, Francis L, Gorantla V, Mountz J, Wang H, Clump II DA, Heron DE, Snyderman C, Skinner HD, Mowery YM. High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab plus /-Docetaxel in Previously-Irradiated HNSCC. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2025. p. S144–S144.